Skip to content
Clinical Trials – home
Verifiedinfo

Mech Sense

Denmark Moelleparkvej 4, 9000 Aalborg, Denmark

  • 1 trial recruiting
  • Drug use disorder · Pancreatitis chronic
  • Adult patients

About Specializations

Mech Sense in Aalborg, Denmark specialises in clinical trials of conditions such as Drug use disorder, Pancreatitis chronic, and other specialisations. This site conducts important research.

Main research areas of the site

Digestive System Research

At Mech Sense in Aalborg, the Department of Gastroenterology and Hepatology is running clinical research focused on Digestive System Diseases, with an emphasis on conditions that affect comfort, digestion, and quality of life.

  • Research in chronic pancreatitis is exploring ways to reduce pain and improve physical function and daily well-being.
  • Studies on opioid induced bowel dysfunction are examining how bowel activity and digestive movement are affected by opioid use.
  • These trials aim to test new treatment approaches and better understand digestive symptoms using objective clinical assessment.

The site combines patient-centered work on symptom relief with research into how the gastrointestinal tract responds to treatment and medication.

Chronic Pancreatitis Studies

One key area of investigation at this research facility is chronic pancreatitis, where trials are focused on easing persistent pain and supporting better everyday functioning for affected patients.

  • Exploring a potential new therapy for painful chronic pancreatitis.
  • Assessing whether treatment can lower symptom burden and improve quality of life.
  • Advancing care for a long-term digestive disease with significant impact on patients' lives.

This research reflects a broader effort to improve treatment options in gastroenterology through carefully designed clinical studies.

Opioid-Related Bowel Function Research

Another important focus is opioid induced bowel dysfunction, where studies are evaluating how medicines and opioids influence bowel transit, motility, secretion, and colon volume.

  • Testing a treatment approach for opioid-related bowel dysfunction.
  • Studying the digestive effects of tramadol in a controlled research setting.
  • Improving understanding of how opioid use alters gastrointestinal performance.

These trials support better diagnosis and management of medication-related digestive problems in patients treated at Mech Sense.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Moelleparkvej 49000 AalborgDenmark
Recruiting now
1 trial
Conditions studied
2
Partner status
Verified

More sites in AalborgDenmark

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

3 clinical trials

Countries:DenmarkDenmark
  • Participants:18–64 years · Healthy volunteers
  • Substances:NALDEMEDINE
  • Sponsor:Aalborg University Hospital
Countries:DenmarkDenmark
  • Participants:18–64 years · Healthy volunteers
  • Substances:Tramadol
  • Sponsor:Aalborg University Hospital
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Aalborg University Hospital
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).